<ul><li>Canid, a healthcare technology company focusing on pediatric vaccine management, has secured $10M in Series A funding led by Telescope Partners with participation from FJ Labs, Brooklyn Bridge Ventures, SeedtoB, and others.</li><li>The total capital raised by Canid now amounts to $12.9M, and the funding will be used for the company's expansion to support independent pediatricians across the U.S.</li><li>Pediatric vaccine management poses significant administrative and financial challenges for independent practices, with physicians spending an average of 15 hours per week on administrative tasks.</li><li>Canid's automated platform, integrated with electronic health records, aims to streamline vaccine management processes, reduce overhead, and provide automated logistics, guaranteed payments, and data-driven patient outreach.</li></ul>

Canid Raises $10M to Streamline Pediatric Vaccine Management for Independent Practices

Discover more